Newron Pharmaceuticals S.p.A.

Director's Dealing • Apr 7, 2025

News Details

Directors’ Dealings | 7 April 2025 17:17

Newron Pharmaceuticals S.p.A.: Stefan Weber, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

07.04.2025 / 17:15 CET/CEST

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Stefan
Last name(s):	Weber

2. Reason for the notification

a) Position / status

Position:	Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Newron Pharmaceuticals S.p.A.

b) LEI

8156002F8C11F80A9740

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	IT0004147952

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
6.901 EUR	34,502.73 EUR

d) Aggregated information

Price	Aggregated volume
6.9010 EUR	34,502.7300 EUR

e) Date of the transaction

07/04/2025; UTC+2

f) Place of the transaction

Name:	Xetra
MIC:	XETR

---

07.04.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	Newron Pharmaceuticals S.p.A.
	via Antonio Meucci 3
	20091 Bresso
	Italy
Internet:	www.newron.com

End of News	EQS News Service

---

97930  07.04.2025 CET/CEST